WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Down 32.6% in August

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the recipient of a significant decline in short interest in the month of August. As of August 14th, there was short interest totaling 31,255 shares, a decline of 32.6% from the July 30th total of 46,353 shares. Based on an average trading volume of 61,760 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.0% of the company’s shares are sold short.

WuXi Biologics (Cayman) Stock Down 4.1%

Shares of OTCMKTS:WXXWY opened at $12.40 on Tuesday. The company has a 50-day moving average price of $10.43 and a 200-day moving average price of $9.41. WuXi Biologics has a 12 month low of $7.30 and a 12 month high of $13.43.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.